Related Experiment Video
Updated: Nov 5, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox
Sergi Ferré1, Xavier Guitart1, César Quiroz1
1Integrative Neurobiology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Triad Building, 333 Cassell Drive, Baltimore, MD 21224, USA.
Akathisia, an urgent need to move, may stem from altered dopamine signaling in the brain. This study suggests distinct mechanisms for drug-induced akathisia and restless legs syndrome involving dopamine and adenosine receptors.
Area of Science:
- Neuroscience
- Pharmacology
- Movement Disorders
Background:
- Akathisia is a distressing movement disorder characterized by an urgent need to move.
- It is frequently associated with dopamine receptor blocking agents (DRBAs) and restless legs syndrome (RLS).
- The precise pathogenetic mechanisms underlying akathisia remain largely unresolved.
Purpose of the Study:
- To propose a novel pathogenetic mechanism for akathisia.
- To differentiate the proposed mechanisms for DRBA-induced akathisia and RLS-related akathisia.
Main Methods:
- The study proposes a theoretical model based on existing neurobiological understanding.
- It integrates knowledge of dopaminergic and adenosinergic systems in the ventral striatum.
- The model considers receptor-heteromer formation and autoreceptor function.
Main Results:
- The proposed mechanism involves increased presynaptic dopaminergic transmission in the ventral striatum.
- This is coupled with strong activation of postsynaptic dopamine D1 receptors, forming complexes with dopamine D3 and adenosine A1 receptors.
- DRBA-induced akathisia is hypothesized to result from autoreceptor inactivation, while RLS-related akathisia may stem from iron deficiency-induced downregulation of striatal presynaptic A1 receptors.
Conclusions:
- Akathisia pathogenesis likely involves complex interactions within the ventral striatal dopaminergic system.
- Distinct neurobiological pathways may underlie akathisia induced by DRBAs versus that associated with RLS.
- Further research into these proposed mechanisms could inform novel therapeutic strategies for akathisia.
Related Concept Videos
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Parkinson's Disease: Overview

